24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
Is the Mumps Vaccine Becoming Less Effective?Autism Now Diagnosed in 1 in Every 44 Children, CDC SaysKids With Uncontrolled Asthma at Higher Odds for Severe COVID-19Nearly 7% of U.S. Kids Have Had a Head Injury or ConcussionAre Your Holiday Gifts on the 'Noisy Toy List'?Many Kids, Teens Think Girls Don't Care About Computer ScienceMost Parents Say Their Kids Aren't Thankful Enough: PollPandemic Curbed Kids' Efforts to Lose Excess WeightClimate Change May Not Increase Allergies in Kids With Asthma: StudyNearly 10% of Younger Kids Have Gotten First COVID Vaccine DoseAHA News: Family-Based Programs Targeting Childhood Obesity Can Be Good for Parents, TooCases of Children's Severe COVID-Linked Illness Were Worse in Second WaveFace Masks Don't Hide Emotions From Kids: StudyTrauma in Childhood Can Harm Health for a Lifetime: StudyAdult 'Picky Eaters' on What Parents Did Right and WrongWHO, CDC Warn of Measles Threat After 22 Million Infants Miss Shots During PandemicWealthier Parents More Likely to Get COVID Vaccines for Young Kids: PollNearly 900,000 U.S. Kids Under 12 Have Gotten Their First COVID ShotNo Evidence Violent Video Games Lead to Real Violence: StudyDo Your Kids Really Need Cough & Cold Meds?AHA News: What Parents Should Know About the COVID-19 Vaccine For 5- to 11-Year-OldsFor Kids Afraid of Needles, These Tips May Help Ease COVID ShotsCDC Signs Off on Pfizer Vaccine for Younger KidsWe've Been Here Before: How Polio Vaccine Rollout Saved Millions of Young LivesVaccinations for Kids Will Be in Full Swing by Nov. 8, White House SaysFDA Approves Pfizer COVID Vaccine for Kids 5-11Attorneys General Warn About Pot Products That Look Like Halloween TreatsCDC Lowers Threshold for Lead Poisoning in Youngest KidsFDA Advisors Approve Emergency Use of Pfizer COVID Vaccine in Kids 5 to 11Moderna Says Its COVID Vaccine Works Well in Children Aged 6 to 11Pediatricians Offer Advice on Keeping Trick-or-Treaters SafeThe No. 1 Cause of Halloween Injuries: Carving the PumpkinPfizer Vaccine Prevents 91% of Symptomatic COVID in Young Children: FDAPfizer Says Lower Dose of Its COVID Vaccine Protects Younger ChildrenWhite House Announces COVID Vaccination Plan for Young KidsMany Parents Worry That Kids Fell Behind in Schooling During PandemicNew Device Might Spot 'Lazy Eye' in Kids EarlierA High-Tech Pointer to Pollutants That Trigger Asthma in KidsU.S. Pediatricians, Psychiatrists Declare 'Emergency' in Child Mental HealthState Spending on Poverty Really Pays Off for Kids: StudyNature Helped Many Kids Cope During Lockdown: StudyTwo-Thirds of Parents of Kids Ages 5-11 Plan to Get Them Vaccinated Against COVID: PollKids Can Carry High, Infectious Levels of COVID CoronavirusBystanders Can Make the Difference for a Drowning ChildAs COVID Cases Drop, Fauci Tells Families to Enjoy HalloweenGolf Cart Injuries Keep Rising Among U.S. KidsStudy Confirms Rise in Child Abuse During COVID PandemicSocial Distancing Kept Kids From Getting Flu, RSVPfizer Seeks FDA Emergency Approval for COVID Vaccine in Younger KidsCould an App Help Kids With Severe Ear Condition Avoid Surgery?
Questions and AnswersLinks
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Child Development & Parenting: Infants (0-2)
Child Development & Parenting: Early (3-7)

Pfizer Says Lower Dose of Its COVID Vaccine Protects Younger Children

HealthDay News
by Robert Preidt
Updated: Oct 22nd 2021

new article illustration

FRIDAY, Oct. 22, 2021 (HealthDay News) -- A lower dose of Pfizer's coronavirus vaccine is 90.7% effective in preventing symptomatic COVID-19 in children aged 5 to 11, according to new clinical trial data from the company.

The data was given to the U.S. Food and Drug Administration on Friday, and the agency is expected to release its own analysis of the trial findings later in the day, The New York Times reported.

Next week, an FDA advisory panel will meet to discuss whether to recommend FDA authorization of the Pfizer vaccine for children aged 5 to 11. It's already available for those 12 and older.

The dose used in the trial that included more than 2,200 children was 10 micrograms, while the adult dose is 30 micrograms. Twice as many study participants received the vaccine as a placebo, the Times reported.

COVID-19 was diagnosed in three children who received the vaccine and 16 of those who received the placebo, indicating it was more than 90% effective. The dosage was safe, and there were only mild side effects, according to Pfizer.

FDA authorization of the vaccine for children aged 5 to 11 could help protect more than 28 million people in the United States, according to the Times.

If the FDA does give the green light to the vaccine for that age group, the U.S. Centers for Disease Control and Prevention would then recommend how the shots should be administered.

More information

Visit the U.S. Food and Drug Administration for more on COVID vaccines.

SOURCE: The New York Times